Sign in

CIK 0001341235 · Non-accelerated filer<br>Smaller reporting company

Aldeyra Therapeutics, Inc.

Sign in to watch
Ticker
ALDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
781-761-4904
Business address
23 BRADFORD STREET, SUITE 1, CONCORD, MA, 01742
Former names
Aldexa Therapeutics, Inc., Neuron Systems Inc
  1. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  2. 10-Q Report Quarterly Report
  3. 8-K Event Regulation FD disclosure
  4. ARS Other Annual Report to Security Holders
  5. DEFA14A Proxy Proxy Materials
  6. DEF 14A Proxy Proxy Statement
  7. 8-K Event Executive or director change
  8. 8-K Event Other events
  9. 4 Derivatives Options or other derivatives
  10. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  11. 4 Open-market buy Director bought 70,000 shares at $1.40 ($98,000)
  12. 4 Open-market buy Principal Financial Officer bought 5,000 shares at $1.42 ($7,100)
  13. 8-K Event Regulation FD disclosure · Other events
  14. S-8 Other Securities Offered to Employees in Benefit Plans
  15. 10-K Report Annual Report
  16. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  17. 8-K Event Executive or director change
  18. 8-K Event Regulation FD disclosure · Other events
  19. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  20. 8-K Event Regulation FD disclosure · Other events

Page 2 of 33 · 650 filings